Pfizer CEO Albert Bourla and his vaccine partner BioNTech have said the companies expect phase 3 data by the end of October—and that an FDA application could soon follow. But more than 60 researchers and bioethicists urged the partners to wait for more safety data before submitting their shot for a green light, Bloomberg reports. The experts called on… Read More »
JOHANNESBURG — At a lecture to peers this month, John Nkengasong showed images that once dogged Africa, with a magazine cover declaring it “The Hopeless Continent.” Then he quoted Ghana’s first president, Kwame Nkrumah: “It is clear that we must find an African solution to our problems, and that this can only be found in… Read More »
“We also have good antiviral drugs that can be used to limit complications, and even preventively to protect against household spread. “Unfortunately, with coronavirus, we do not have any of these things yet.” “We are already seeing a huge upsurge in people with minor respiratory symptoms – children being sent home from school with coughs… Read More »
Albert Bourla, chief executive officer of Pfizer pharmaceutical company, arrives to ring the closing bell at the New York Stock Exchange. Drew Angerer | Getty Images Pfizer CEO Albert Bourla warned on Tuesday that people who don’t take the Covid-19 vaccine will become a “weak link” that allows the coronavirus to spread. Bourla, whose company is in… Read More »